Related Experiment Video
Updated: Dec 6, 2025

11:17
Sensing of Barrier Tissue Disruption with an Organic Electrochemical Transistor
Published on: February 10, 2014
12.0K
New Frontiers for Selective Biosensing with Biomembrane-Based Organic Transistors
Claudia Lubrano1,2, Giovanni Maria Matrone1, Gennaro Iaconis3
1Tissue Electronics, Istituto Italiano di Tecnologia, 80125 Naples, Italy.
ACS Nano
|October 14, 2020
Summary
Organic transistor biosensors coupled with artificial membranes offer enhanced sensitivity and selectivity for detecting various analytes. This advancement paves the way for developing high-throughput screening platforms in healthcare and environmental monitoring.
Area of Science:
- Biotechnology
- Materials Science
- Analytical Chemistry
Background:
- Biosensing is crucial for healthcare, drug screening, and environmental monitoring.
- Transistor-based devices offer fast, low-cost analyte detection but lack selectivity.
- Organic transistors are promising for biosensing due to their biological compatibility.
Purpose of the Study:
- To review recent advancements in organic-transistor-based biosensors.
- To highlight the role of artificial membranes in improving biosensor performance.
- To discuss future applications in high-throughput screening.
Main Methods:
- Review of recent literature on organic-transistor biosensors.
- Focus on strategies for immobilizing bioreceptors on organic transistors.
- Integration of artificial membranes with organic transistor platforms.
Main Results:
- Coupling organic transistors with artificial membranes significantly enhances sensitivity and selectivity.
- Organic-transistor biosensors demonstrate potential for detecting diverse biomolecules.
- These biosensors are adaptable for various applications, including disease diagnosis and pollution control.
Conclusions:
- Organic-transistor biosensors integrated with artificial membranes represent a significant breakthrough.
- This technology offers a pathway to improved biosensing capabilities.
- Future potential lies in developing multimodal, high-throughput screening platforms.

